(Marietta, GA) MiMedx group Inc. is a leading regenerative medicine company utilizing human amniotic tissue reported record revenue for the 3rd quarter of 2014.
MiMedx Third Quarter Revenue Of $33.5 Million Exceeds Upper End Of Guidance (CNN)
Parker H. "Pete" Petit